Innate Immune Responses and Rapid Control of Inflammation in African Green Monkeys Treated or Not with Interferon-Alpha during Primary SIVagm Infection

PLoS Pathogens

Volumn 10, Issue 7, 2014, Pages

  Jacquelin, Béatrice ^a   Petitjean, Gaël ^a   Kunkel, Désirée ^a   Liovat, Anne Sophie ^a   Jochems, Simon P ^a,b   Rogers, Kenneth A ^c   Ploquin, Mickaël J ^a   Madec, Yoann ^a   Barré Sinoussi, Françoise ^a   Dereuddre Bosquet, Nathalie ^d   Lebon, Pierre ^e   Le Grand, Roger ^d   Villinger, François ^c   Müller Trutwin, Michaela ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c EMORY UNIVERSITY   (United States)

^d INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^e HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CYTOKINE;

ANIMAL; CHLOROCEBUS AETHIOPS; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; PATHOLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; CYTOKINES; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INFLAMMATION; INTERFERON-ALPHA; LYMPHOCYTE ACTIVATION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES;

EID: 84905367955     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004241     Document Type: Article

References (91)

1. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859-870.
2. Kuller LH, Tracy R, Belloso W, Wit SD, Drummond F, et al. (2008) Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection. PLoS Med 5: e203.
3. Tien PC, Choi AI, Zolopa AR, Benson C, Tracy R, et al. (2010) Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes 55: 316-322 310.1097/QAI.1090b1013e3181e66216.
4. Liovat AS, Rey-Cuille MA, Lecuroux C, Jacquelin B, Girault I, et al. (2012) Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection. PLoS ONE 7: e46143.
5. Roberts L, Passmore JA, Williamson C, Little F, Bebell LM, et al. (2010) Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. Aids 24: 819-831.
6. Reschner A, Hubert P, Delvenne P, Boniver J, Jacobs N, (2008) Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response. Clinical & Experimental Immunology 152: 219-226.
7. Frasca L, Lande R, (2011) Overlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functions. ScientificWorldJournal 11: 2071-2090.
8. Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, et al. (2005) Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 115: 3265-3275.
9. Fonteneau J-F, Larsson M, Beignon A-S, McKenna K, Dasilva I, et al. (2004) Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells. J Virol 78: 5223-5232.
10. Muller-Trutwin M, Hosmalin A, (2005) Role for plasmacytoid dendritic cells in anti-HIV innate immunity. Immunol Cell Biol 83: 578-583.
11. Kwa S, Kannanganat S, Nigam P, Siddiqui M, Shetty RD, et al. (2011) Plasmacytoid dendritic cells are recruited to the colorectum and contribute to immune activation during pathogenic SIV infection in rhesus macaques. Blood 118: 2763-2773.
12. Nascimbeni M, Perie L, Chorro L, Diocou S, Kreitmann L, et al. (2009) Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-alpha expression. Blood 113: 6112-6119.
13. Brown KN, Wijewardana V, Liu X, Barratt-Boyes SM, (2009) Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection. PLoS Pathog 5: e1000413.
14. Lehmann C, Lafferty M, Garzino-Demo A, Jung N, Hartmann P, et al. (2010) Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients. PLoS One 5: e11110.
15. Reeves RK, Evans TI, Gillis J, Wong FE, Kang G, et al. (2012) SIV Infection Induces Accumulation of Plasmacytoid Dendritic Cells in the Gut Mucosa. Journal of Infectious Diseases 206: 1462-1468.
16. Conry SJ, Milkovich KA, Yonkers NL, Rodriguez B, Bernstein HB, et al. (2009) Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function. J Virol 83: 11175-11187.
17. Reitano KN, Kottilil S, Gille CM, Zhang X, Yan M, et al. (2009) Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection. AIDS Res Hum Retroviruses 25: 1029-1037.
18. Audige A, Urosevic M, Schlaepfer E, Walker R, Powell D, et al. (2006) Anti-HIV State but Not Apoptosis Depends on IFN Signature in CD4+ T Cells. J Immunol 177: 6227-6237.
19. Fenton-May AE, Dibben O, Emmerich T, Ding H, Pfafferott K, et al. (2013) Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology 10: 146.
20. Hosmalin A, Lebon P, (2006) Type I interferon production in HIV-infected patients. J Leukoc Biol 80: 984-993.
21. Bosinger SE, Hosiawa KA, Cameron MJ, Persad D, Ran L, et al. (2004) Gene expression profiling of host response in models of acute HIV infection. J Immunol 173: 6858-6863.
22. Hyrcza MD, Kovacs C, Loutfy M, Halpenny R, Heisler L, et al. (2007) Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. J Virol 81: 3477-3486.
23. Sedaghat AR, German J, Teslovich TM, Cofrancesco J Jr, Jie CC, et al. (2008) Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics. J Virol 82: 1870-1883.
24. Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, et al. (2009) Glycerol monolaurate prevents mucosal SIV transmission. Nature 458: 1034-1038.
25. Herbeuval J-P, Shearer GM, (2007) HIV-1 immunopathogenesis: How good interferon turns bad. Clinical Immunology 123: 121.
26. Keir ME, Rosenberg MG, Sandberg JK, Jordan KA, Wiznia A, et al. (2002) Generation of CD3+CD8low Thymocytes in the HIV Type 1-Infected Thymus. J Immunol 169: 2788-2796.
27. Liovat AS, Jacquelin B, Ploquin MJ, Barre-Sinoussi F, Muller-Trutwin MC, (2009) African non human primates infected by SIV- why don't they get sick? Lessons from studies on the early phase of non-pathogenic SIV infection. Curr HIV Res 7: 39-50.
28. Sodora DL, Allan JS, Apetrei C, Brenchley JM, Douek DC, et al. (2009) Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 15: 861-865.
29. Gueye A, Diop OM, Ploquin MJ, Kornfeld C, Faye A, et al. (2004) Viral load in tissues during the early and chronic phase of non-pathogenic SIVagm infection. J Med Primatol 33: 83-97.
30. Kornfeld C, Ploquin MJ, Pandrea I, Faye A, Onanga R, et al. (2005) Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 115: 1082-1091.
31. Chakrabarti LA, Lewin SR, Zhang L, Gettie A, Luckay A, et al. (2000) Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J Virol 74: 1209-1223.
32. Pandrea I, Cornell E, Wilson C, Ribeiro RM, Ma D, et al. (2012) Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates. Blood 120: 1357-1366.
33. Bosinger SE, Johnson ZP, Folkner KA, Patel N, Hashempour T, et al. (2013) Intact Type I Interferon Production and IRF7 Function in Sooty Mangabeys. PLoS Pathog 9: e1003597.
34. Bosinger SE, Li Q, Gordon SN, Klatt NR, Duan L, et al. (2009) Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 119: 3556-3572.
35. Campillo-Gimenez L, Laforge M, Fay M, Brussel A, Cumont MC, et al. (2010) Nonpathogenesis of simian immunodeficiency virus infection is associated with reduced inflammation and recruitment of plasmacytoid dendritic cells to lymph nodes, not to lack of an interferon type I response, during the acute phase. J Virol 84: 1838-1846.
36. Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, et al. (2009) Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 119: 3544-3555.
37. Harris LD, Tabb B, Sodora DL, Paiardini M, Klatt NR, et al. (2010) Downregulation of Robust Acute Type I Interferon Responses Distinguishes Nonpathogenic Simian Immunodeficiency Virus (SIV) Infection of Natural Hosts from Pathogenic SIV Infection of Rhesus Macaques. J Virol 84: 7886-7891.
38. Diop OM, Ploquin MJ, Mortara L, Faye A, Jacquelin B, et al. (2008) Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome. J Virol 82: 5145-5152.
39. Pereira LE, Johnson RP, Ansari AA, (2008) Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection. Cellular Immunology 254: 10-19.
40. Lederer S, Favre D, Walters KA, Proll S, Kanwar B, et al. (2009) Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization. PLoS Pathog 5: e1000296.
41. Meythaler M, Martinot A, Wang Z, Pryputniewicz S, Kasheta M, et al. (2009) Differential CD4+ T-Lymphocyte Apoptosis and Bystander T-Cell Activation in Rhesus Macaques and Sooty Mangabeys during Acute Simian Immunodeficiency Virus Infection. J Virol 83: 572-583.
42. Favre D, Lederer S, Kanwar B, Ma ZM, Proll S, et al. (2009) Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 5: e1000295.
43. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, et al. (2009) Induction of a striking systemic cytokine cascade prior to peak viraemia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol pp. 3719-3733.
44. Fukazawa Y, Park H, Cameron MJ, Lefebvre F, Lum R, et al. (2012) Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines. Nat Med 18: 1673-1681.
45. Buettner M, Bode U, (2012) Lymph node dissection - understanding the immunological function of lymph nodes. Clinical & Experimental Immunology 169: 205-212.
46. Pandrea I, Kornfeld C, Ploquin MJ, Apetrei C, Faye A, et al. (2005) Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol 79: 6249-6259.
47. Wijewardana V, Soloff AC, Liu X, Brown KN, Barratt-Boyes SM, (2010) Early Myeloid Dendritic Cell Dysregulation is Predictive of Disease Progression in Simian Immunodeficiency Virus Infection. PLoS Pathog 6: e1001235.
48. Wijewardana V, Kristoff J, Xu C, Ma D, Haret-Richter G, et al. (2013) Kinetics of myeloid dendritic cell trafficking and activation: impact on progressive, nonprogressive and controlled SIV infections. PLoS Pathog 9: e1003600.
49. Brown KN, Trichel A, Barratt-Boyes SM, (2007) Parallel Loss of Myeloid and Plasmacytoid Dendritic Cells from Blood and Lymphoid Tissue in Simian AIDS. The Journal of Immunology 178: 6958-6967.
50. Dillon SM, Robertson KB, Pan SC, Mawhinney S, Meditz AL, et al. (2008) Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection. J Acquir Immune Defic Syndr 48: 1-12.
51. Dambaeva SV, Breburda EE, Durning M, Garthwaite MA, Golos TG, (2009) Characterization of decidual leukocyte populations in cynomolgus and vervet monkeys. J Reprod Immunol 80: 57-69.
52. Webster RL, Johnson RP, (2005) Delineation of multiple subpopulations of natural killer cells in rhesus macaques. Immunology 115: 206-214.
53. Cooper MA, Fehniger TA, Caligiuri MA, (2001) The biology of human natural killer-cell subsets. Trends Immunol 22: 633-640.
54. Cousens LP, Peterson R, Hsu S, Dorner A, Altman JD, et al. (1999) Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J Exp Med 189: 1315-1328.
55. Giavedoni LD, Velasquillo MC, Parodi LM, Hubbard GB, Hodara VL, (2000) Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol 74: 1648-1657.
56. Milush JM, Stefano-Cole K, Schmidt K, Durudas A, Pandrea I, et al. (2007) Mucosal innate immune response associated with a timely humoral immune response and slower disease progression after oral transmission of simian immunodeficiency virus to rhesus macaques. J Virol 81: 6175-6186.
57. Vanderford TH, Slichter C, Rogers KA, Lawson BO, Obaede R, et al. (2012) Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation. Blood 119: 5750-5757.
58. Wills RJ, Spiegel HE, Soike KF, (1984) Pharmacokinetics of recombinant alpha A interferon following I.V. infusion and bolus, I.M., and P.O. administrations to African green monkeys. J Interferon Res 4: 399-409.
59. Jazayeri JA, Carroll GJ, (2008) Fc-based cytokines: prospects for engineering superior therapeutics. BioDrugs 22: 11-26.
60. Omer FM, de Souza JB, Riley EM, (2003) Differential induction of TGF-beta regulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections. J Immunol 171: 5430-5436.
61. Zuniga EI, Liou LY, Mack L, Mendoza M, Oldstone MB, (2008) Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections. Cell Host Microbe 4: 374-386.
62. Asmuth DM, Abel K, George MD, Dandekar S, Pollard RB, et al. (2008) Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques. J Med Primatol 37: 26-30.
63. Goujard C, Emilie D, Roussillon C, Godot V, Rouzioux C, et al. (2012) Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM Trial. Aids 26: 1895-1905.
64. Azzoni L, Foulkes AS, Papasavvas E, Mexas AM, Lynn KM, et al. (2013) Reply to zur Wiesch and van Lunzen. Journal of Infectious Diseases 208: 363.
65. Durudas A, Milush JM, Chen HL, Engram JC, Silvestri G, et al. (2009) Elevated levels of innate immune modulators in lymph nodes and blood are associated with more-rapid disease progression in simian immunodeficiency virus-infected monkeys. J Virol 83: 12229-12240.
66. Simmons RP, Scully EP, Groden EE, Arnold KB, Chang JJ, et al. (2013) HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathways. Aids 27: 2505-2517.
67. Kamat A, Misra V, Cassol E, Ancuta P, Yan Z, et al. (2012) A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy. PLoS ONE 7: e30881.
68. Keating SM, Golub ET, Nowicki M, Young M, Anastos K, et al. (2011) The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women. Aids 25: 1823-1832.
69. Hilkens CM, Schlaak JF, Kerr IM, (2003) Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J Immunol 171: 5255-5263.
70. Kanda N, Shimizu T, Tada Y, Watanabe S, (2007) IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. Eur J Immunol 37: 338-350.
71. Yeruva S, Ramadori G, Raddatz D, (2008) NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines. Int J Colorectal Dis 23: 305-317.
72. Pulit-Penaloza JA, Scherbik SV, Brinton MA, (2012) Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells. Virology 425: 82-94.
73. Rustagi A, Gale M Jr, (2014) Innate Antiviral Immune Signaling, Viral Evasion and Modulation by HIV-1. Journal of Molecular Biology 426: 1161-1177.
74. Hasan M, Koch J, Rakheja D, Pattnaik AK, Brugarolas J, et al. (2013) Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes. Nat Immunol 14: 61-71.
75. Malcolm KC, Worthen GS, (2003) Lipopolysaccharide Stimulates p38-dependent Induction of Antiviral Genes in Neutrophils Independently of Paracrine Factors. Journal of Biological Chemistry 278: 15693-15701.
76. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
77. Handley SA, Thackray LB, Zhao G, Presti R, Miller AD, et al. (2012) Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome. Cell 151: 253-266.
78. Aguet M, Grobke M, Dreiding P, (1984) Various human interferon alpha subclasses cross-react with common receptors: their binding affinities correlate with their specific biological activities. Virology 132: 211-216.
79. Gibbert K, Joedicke JJ, Meryk A, Trilling M, Francois S, et al. (2012) Interferon-alpha Subtype 11 Activates NK Cells and Enables Control of Retroviral Infection. PLoS Pathogens 8: e1002868.
80. Moll HP, Maier T, Zommer A, Lavoie T, Brostjan C, (2011) The differential activity of interferon-alpha subtypes is consistent among distinct target genes and cell types. Cytokine 53: 52-59.
81. Silvestri G, Fedanov A, Germon S, Kozyr N, Kaiser WJ, et al. (2005) Divergent Host Responses during Primary Simian Immunodeficiency Virus SIVsm Infection of Natural Sooty Mangabey and Nonnatural Rhesus Macaque Hosts. J Virol 79: 4043-4054.
82. MacDonald KPA, Munster DJ, Clark GJ, Dzionek A, Schmitz J, et al. (2002) Characterization of human blood dendritic cell subsets. Blood 100: 4512-4520.
83. Piccioli D, Tavarini S, Borgogni E, Steri V, Nuti S, et al. (2007) Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. Blood 109: 5371-5379.
84. O'Brien M, Manches O, Sabado RL, Jimenez Baranda S, Wang Y, et al. (2011) Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-alpha-producing and partially matured phenotype. J Clin Invest 121: 1088-1101.
85. Bruel T, Dupuy S, Demoulins T, Rogez-Kreuz C, Dutrieux J, et al. (2014) Plasmacytoid dendritic cell dynamics tune interferon-alfa production in SIV-infected cynomolgus macaques. PLoS Pathog 10: e1003915.
86. Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, et al. (2002) Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169: 4279-4287.
87. Martinot AJ, Meythaler M, Pozzi L-A, Dalecki Boisvert K, Knight H, et al. (2013) Acute SIV Infection in Sooty Mangabey Monkeys Is Characterized by Rapid Virus Clearance from Lymph Nodes and Absence of Productive Infection in Germinal Centers. PLoS ONE 8: e57785.
88. Brenchley JM, Vinton C, Tabb B, Hao XP, Connick E, et al. (2012) Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections. Blood 120: 4172-4181.
89. Meythaler M, Wang Z, Martinot A, Pryputniewicz S, Kasheta M, et al. (2011) Early induction of polyfunctional simian immunodeficiency virus (SIV)-specific T lymphocytes and rapid disappearance of SIV from lymph nodes of sooty mangabeys during primary infection. J Immunol 186: 5151-5161.
90. Diop OM, Gueye A, Dias-Tavares M, Kornfeld C, Faye A, et al. (2000) High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J Virol 74: 7538-7547.
91. Ploquin MJ, Jacquelin B, Jochems SP, Barre-Sinoussi F, Muller-Trutwin MC, (2012) Innate immunity in the control of HIV/AIDS: recent advances and open questions. Aids 26: 1269-1279.